NCT04985643Active, not recruiting
A Study of Real Life Treatment for Multiple Myeloma (MM)
Local, Multicentre, Non-Interventional Study of Early Diagnostics of Multiple Myeloma Relapses Evaluation in Real Life Practice in the Russian Federation
Source: ClinicalTrials.gov · Last updated 22 May 2026
Brief summary (registry, in English)
The main aim of this study is to learn how long it takes for people with MM to have a relapse after their first treatment. Not all participants will have a relapse during the study. Participants will visit their clinic every 3 months and be treated according to their clinic's standard practice. The study sponsor will not be involved in how participants are treated but will provide instructions on how the clinics will record what happens during the study.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 357 (actual)
- First submitted
- 29 Jul 2021
- Start date
- 18 Feb 2022
- Primary completion date
- 20 Jun 2027
- Lead sponsor
- Takeda
- Diseases
- Multiple myeloma
- NCT number
- NCT04985643
What you commit to
- Study type: Observational
- Participants enrolled: 357
- From 18 Feb 2022 to the primary completion date, 20 Jun 2027
- 24 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- With NDMM eligible and non-eligible for a HDT-ASCT who have had SD or PD to the ongoing standard of care (SoC) induction (1st line) therapy that has been started within 3 months before the inclusion.
- Current, previous (within the last year) or planned (for the next 15-20 months) participation in interventional clinical trial.
Who the study is looking for
- With newly diagnosed multiple myeloma (NDMM) eligible and non-eligible for a high-dose therapy and autologous stem cell transplantation (HDT-ASCT) who have had a response (defined as CR, VGPR, or PR) to the ongoing SoC induction (1st line) therapy that has been started within 3 months before the inclusion.
- Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2 at the time of inclusion.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (24)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Altai Regional Clinical Hospital Coordinator of this site? Confirm its status | Barnaul | Russia | Unknown status |
| BaltikMed Clinic Coordinator of this site? Confirm its status | Kaliningrad | Russia | Unknown status |
| Kaluga Regional Clinical Hospital Coordinator of this site? Confirm its status | Kaluga | Russia | Unknown status |
| Republican Clinical Hospital of the Ministry of Health of the Republic of Tatarstan Coordinator of this site? Confirm its status | Kazan' | Russia | Unknown status |
| City Clinical Hospital No. 1 named after prof. S.I.Sergeev Coordinator of this site? Confirm its status | Khabarovsk | Russia | Unknown status |
| District Clinical Hospital Coordinator of this site? Confirm its status | Khanty-Mansiysk | Russia | Unknown status |
| Kirov Research Institute of Hematology and Blood Transfusion Coordinator of this site? Confirm its status | Kirov | Russia | Unknown status |
| GUZ "Lipetsk City Hospital No. 3" Free Falcon " Coordinator of this site? Confirm its status | Lipetsk | Russia | Unknown status |
| Herzen Moscow Scientific Research Oncological Institute Coordinator of this site? Confirm its status | Moscow | Russia | Unknown status |
| National Research Center of Hematology of the Ministry of Health Coordinator of this site? Confirm its status | Moscow | Russia | Unknown status |
| Moscow Regional Research Clinical Institute n.a. M.F. Vladimirsky Coordinator of this site? Confirm its status | Moscow | Russia | Unknown status |
| City Clinical Hospital No. 12 Coordinator of this site? Confirm its status | Nizhny Novgorod | Russia | Unknown status |
| Novosibirsk State Medical University, Department of Therapy, Hematology and Transfusiology based on City Clinical Hospital No. 2 Coordinator of this site? Confirm its status | Novosibirsk | Russia | Unknown status |
| Orenburgskaya Regional Clinical Hospital n.a. V.I. Voinova Coordinator of this site? Confirm its status | Orenburg | Russia | Unknown status |
| "Republican hospital named after V. A. Baranov" Coordinator of this site? Confirm its status | Petrozavodsk | Russia | Unknown status |
| City Clinical Hospital No. 31 Coordinator of this site? Confirm its status | Saint Petersburg | Russia | Unknown status |
| Razumovskiy Saratov State Medical University, University Clinical Coordinator of this site? Confirm its status | Saratov | Russia | Unknown status |
| Smolensk Clinical Hospital of Russian Railways-Medicine Coordinator of this site? Confirm its status | Smolensk | Russia | Unknown status |
| Surgut Regional Clinical Hospital Coordinator of this site? Confirm its status | Surgut | Russia | Unknown status |
| Tomsk Regional Clinical Hospital Coordinator of this site? Confirm its status | Tomsk | Russia | Unknown status |
| Republican Clinical Hospital named after G.G. Kuvatov Coordinator of this site? Confirm its status | Ufa | Russia | Unknown status |
| Ulyanovsk Regional Clinical Hospital Coordinator of this site? Confirm its status | Ulyanovsk | Russia | Unknown status |
| Clinic Akademicheskaya LLC Coordinator of this site? Confirm its status | Volgograd | Russia | Unknown status |
| Vologda Regional Clinical Hospital Coordinator of this site? Confirm its status | Vologda | Russia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.